Journal for ImmunoTherapy of Cancer (Nov 2023)
108 Unveiling the diversity in melanoma immunotherapy response biomarkers between lymph node and non-lymph node biopsies
- Iris Barshack,
- Ronnie Shapira-Frommer,
- Kenneth Bloom,
- Nethanel Asher,
- Guy Ben-Betzalel,
- Becky Arbiv,
- Assaf Debby,
- Ron Elran,
- Pinchas Birnbaum,
- Shai Bookstein,
- Tal Dankovich,
- Lena Tsabari,
- Yuval Shachaf,
- Yoad Cohen,
- Amit Bart,
- Oscar Puig,
- Ettai Markovits
Affiliations
- Iris Barshack
- 2Sheba Medical Center, Ramat Gan, Israel
- Ronnie Shapira-Frommer
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- Kenneth Bloom
- 1Invicro, a Konica Minolta Company, Boston, MA, USA
- Nethanel Asher
- 2Sheba Medical Center, Ramat Gan, Israel
- Guy Ben-Betzalel
- Ella Lemelbaum Institute for Immuno-Oncology, Sheba Medical Center at Tel Hashomer, Tel Hashomer, Israel
- Becky Arbiv
- 1Nucleai, Tel Aviv, Israel
- Assaf Debby
- 2Sheba Medical Center, Ramat Gan, Israel
- Ron Elran
- 1Nucleai, Tel Aviv, Israel
- Pinchas Birnbaum
- 1Nucleai, Tel Aviv, Israel
- Shai Bookstein
- 1Nucleai, Tel Aviv, Israel
- Tal Dankovich
- 1Nucleai, Tel Aviv, Israel
- Lena Tsabari
- 1Nucleai, Tel Aviv, Israel
- Yuval Shachaf
- 1Nucleai, Tel Aviv, Israel
- Yoad Cohen
- 1Nucleai, Tel Aviv, Israel
- Amit Bart
- 1Nucleai, Tel Aviv, Israel
- Oscar Puig
- 1Nucleai, Tel Aviv, Israel
- Ettai Markovits
- 1Nucleai, Tel Aviv, Israel
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0108
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.
